The filament sits in the fluid between your skin cells rather than your blood, so the number on your phone is a smoothed estimate. It lags your blood by 5–10 minutes during fast changes 1, and any single reading can be off by 10–15 mg/dL. The shape of your curve over hours is reliable; the value at 2:47pm is not.
The reason the category exists is that two people can eat the same breakfast and one climbs to 130 mg/dL while the other hits 180 mg/dL, at the same weight and fasting sugar 2 3. About 15% of healthy adults run patterns that fasting glucose and HbA1c never catch 4.
Here is the part the marketing skips. In diabetes the case is settled. But nobody has shown that a healthy adult wearing a CGM improves a single hard number a month after taking it off. The non-diabetic pitch is diabetes evidence, extrapolated.
Wear it with a question, and give it an end date. Two or three sensors over four to six weeks gets you almost everything it will ever tell you.
Week one is where the surprise lands. The smoothie you thought was healthy spikes you harder than the omelette; the walk after lunch flattens the afternoon slump. Three months on, a handful of changes survive: a different breakfast, a walk after dinner. The reverse-your-trajectory pitch has no backing 3.
If the real question is "am I metabolically healthy," fasting glucose and HbA1c from an annual draw answer it cheaper, with a validated threshold 6. The CGM earns its place only for the narrower question of which of your meals do what. Watches and rings that advertise glucose insights are not measuring glucose.
Budget $90–180 for the full course. The trap is the subscription layer: Levels, Nutrisense and the rest bundle coaching and a dashboard at $200–$400 a year, selling continuous wear a four-week project doesn't need.
The fine print — when to skip it, and what people get wrong
Skip it with any eating-disorder history: the constant readout maps straight onto restrictive eating. Skip it with health anxiety. If you take insulin or sulfonylureas, or you are pregnant, use the validated device your doctor recommends, not the pharmacy-shelf one 1.
A single spike above 140 is not pre-diabetes; healthy young adults do it after a bagel 5. Flat lines are not the goal. Whether swapping your breakfast on this data makes you healthier has never been tested 3.
Habits drift back within weeks of taking the sensor off; bank the lessons and let the rest fade. If every meal starts to feel like a test, take it off early. A compression low from sleeping on the sensor, or a wild first-day value, is the device misreading.
- 1Klonoff DC, Ahn D, Drincic A (2017). Continuous glucose monitoring: A review of the technology and clinical use. Diabetes Research and Clinical Practice. link
- 2Zeevi D, Korem T, Zmora N, et al. (2015). Personalized Nutrition by Prediction of Glycemic Responses. Cell. link
- 3Berry SE, Valdes AM, Drew DA, et al. (2020). Human postprandial responses to food and potential for precision nutrition. Nature Medicine. link
- 4Hall H, Perelman D, Breschi A, et al. (2018). Glucotypes reveal new patterns of glucose dysregulation. PLOS Biology. link
- 5Shah VN, DuBose SN, Li Z, et al. (2019). Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study. Journal of Clinical Endocrinology & Metabolism. link
- 6American Diabetes Association (2024). Standards of Care in Diabetes—2024: Diabetes Technology. Diabetes Care. link
დაკავშირებული სახელმძღვანელოში (13)
- — A CGM is one way to see for yourself how a sweetener swap flattens your sugar response.
- — If you're trialing a metabolic supplement like berberine, a short CGM stint tells you whether it's doing anything for your glucose.
- — Breakfast is the clearest experiment to run on a CGM: same food, different order, watch the spike change.
- — Like a calorie app, a CGM is best read as a relative signal over a couple of weeks, not a precise daily ledger you trust to the digit.
- — The eye exam catches the damage; tight glucose control is what prevents it. A monitor shows you the spikes that quietly harm the retina.
- — A CGM lets you watch food order flatten your own post-meal spike in real time.
- — A CGM lets you watch your own glucose curve instead of guessing from a food's published score.
- — A CGM in a healthy person throws off 'spikes' that look alarming against an optimal-range mindset but mean nothing — read them with the same skepticism.
- — Same trap as a glucose sensor: great for the trend, misleading as a daily score. Read the weeks, not last night.
- — Once T1D risk is known, a glucose monitor is how families catch the rise before it becomes a crisis.
- — A glucose monitor shows whether eating earlier in your window actually flattens your spikes — TRE's main claim.
- — A two-week CGM shows which foods spike you — fast feedback in the window where habits are forming.
- — A sensor lets you see it for yourself: a ten-minute walk after dinner really does blunt the glucose spike.
Continuous Glucose Monitors (CGMs)
Stelo: ~$89 for two 15-day sensors. A standard 2–4 week investigative course is $90–$180 total; insurance does not reimburse OTC CGMs in non-diabetics. Third-party coaching subscriptions (Levels, Nutrisense) push the annual total to $400–$600 if continued.
Sensor application (~5 min), 14–15 days of wear, meal-and-context logging for the wear window, then interpretation. Minor lifestyle adjustment plus moderate cognitive effort to read the data; the work compresses into 2–4 weeks rather than running indefinitely.
Diabetes evidence is strong (DIAMOND, GOLD, MOBILE — Beck 2017, Lind 2017, Martens 2021); non-diabetic evidence is sparse and observational (Hall 2018, Berry 2020, Shah 2019, Zeevi 2015). No RCT shows that non-diabetic CGM use improves any biomarker or hard endpoint beyond the wear window.
A two-to-four-week structured wear surfaces personal high-glycemic meals and confirms post-meal-walk and exercise effects on the user's own data, producing modest dietary tweaks (Berry et al. PREDICT-1, Nature Med 2020; Zeevi et al. Cell 2015). The trial literature stops there — no biomarker improvement has been demonstrated beyond the wear window.
Identifying personal post-meal glucose spikes lets a sub-set of users reduce reactive afternoon slumps; the Hall 2018 glucotype data shows 15% of nominally healthy adults run patterns that fasting glucose misses and that align with subjective post-meal fatigue. No trial demonstrates daily energy improvement in non-diabetic adults.
Same mechanism as energy: trimming the highest-glycemic personal meals can reduce postprandial cognitive dips in users who run high-variability patterns (Hall et al. PLOS Biology 2018). The effect is small, behaviour-mediated, and not formally tested in non-diabetic adults.